Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Diagnosis of Multiple Cancer and Monitoring of Minimal Residual Tumors After Treatment Using Blood and High-Sensitivity Genetic Analysis Techniques

NCT07035587 is registered in ClinicalTrials.gov with Yonsei University as lead sponsor.

NCT NCT07035587
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07035587 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Diagnosis of Multiple Cancer and Monitoring of Minimal Residual Tumors After Treatment Using Blood and High-Sensitivity Genetic Analysis Techniques
Lead sponsor
Yonsei University
Phase
Observational
Overall status
Recruiting
Start date
August 21, 2024
Completion date
July 28, 2029
Enrollment
1,200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal neoplasms, esophageal neoplasms, lung neoplasms, neoplasm micrometastasis, neoplasms, ovarian neoplasms, pancreatic neoplasms, stomach neoplasms